data mining; diseases; drugs; kidney; liver; medical computing; molecular biophysics; proteins; APRF; CCR2/5; CMKBR2/5; Chinese herbal formula; Duhuo-Jisheng-Tang; FDA approved RA drug targets; GNT1; JAK3; RA OMIM genes; STAT1/3; UGT1A9; biomedical domains; chemical compound; compositional herbal medicine; kidney; knowledge databases; liver; molecule mechanism; pathways; potential therapeutic agents; rheumatoid arthritis; syndrome dual deficiency; system-level regulation; target protein; therapeutic clinical effect; Arthritis; Chemical compounds; Databases; Diseases; Drugs; Protein engineering; Proteins; Duhuo-Jisheng-Tang; molecular mechanism; rheumatoid arthritis; traditional Chinese medicine;
机译:使用内源性,慢性,类风湿性关节炎的K / BXN小鼠模型,用于评估潜在免疫球蛋白的治疗剂,包括IVIG和FC-μTP-L309c,一种重组IgG1 Fc六聚体
机译:类风湿关节炎中生物制剂的治疗药物监测是否有潜力?
机译:是否存在对类风湿性关节炎的生物剂的治疗药物监测?
机译:方风堂治疗类风湿关节炎的潜在药物
机译:TRP通道在类风湿性关节炎滑膜纤维细胞靶向中的治疗潜力
机译:使用内源性慢性类风湿关节炎的K / BxN小鼠模型评估潜在的基于免疫球蛋白的治疗剂包括IVIg和Fc-μTP-L309C一种重组IgG1 Fc六聚体
机译:基线基因表达特征的鉴定预测类风湿关节炎对三种生物制剂的治疗反应:一项回顾性观察研究